Tech Company Financing Transactions

Sebacia Funding Round

Sebacia, based in Duluth, secured $36 million in funding from Versant Ventures, Accuitive Medical Ventures and Domain Associates.

Transaction Overview

Company Name
Announced On
7/26/2017
Transaction Type
Debt
Venture Equity
Amount
$36,000,000
Round
Series D
Investors

Versant Ventures (Lead Investor) (Beckie Robertson)

Accuitive Medical Ventures

Domain Associates (Todd Brady)

Hercules Technology Growth Capital

Partners Innovation Fund

Salem Partners (John Dyett)

Proceeds Purpose
Sebacia intends to use the proceeds from the financing to complete a U.S. pivotal trial with expected results reporting by mid-2018, with submission and FDA response expected by the end of 2018.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
2905 Premiere Pkwy. 150
Duluth, GA 30097
USA
Email Address
Overview
Sebacia, Inc. is a private medical device company dedicated to creating new light-based therapies for the treatment of dermatological conditions.
Profile
Sebacia LinkedIn Company Profile
Social Media
Sebacia Company Twitter Account
Company News
Sebacia News
Facebook
Sebacia on Facebook
YouTube
Sebacia on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Anthony Lando
  Anthony Lando LinkedIn Profile  Anthony Lando Twitter Account  Anthony Lando News  Anthony Lando on Facebook
Chief Financial Officer
Robert Leslie
  Robert Leslie LinkedIn Profile  Robert Leslie Twitter Account  Robert Leslie News  Robert Leslie on Facebook
Chief Operating Officer
Todd Meyer
  Todd Meyer LinkedIn Profile  Todd Meyer Twitter Account  Todd Meyer News  Todd Meyer on Facebook
Chief Technical Officer
Dilip Paithankar
  Dilip Paithankar LinkedIn Profile  Dilip Paithankar Twitter Account  Dilip Paithankar News  Dilip Paithankar on Facebook
VP - Bus. Development
Cory Anderson
  Cory Anderson LinkedIn Profile  Cory Anderson Twitter Account  Cory Anderson News  Cory Anderson on Facebook
VP - Engineering
Pedro Medrano
  Pedro Medrano LinkedIn Profile  Pedro Medrano Twitter Account  Pedro Medrano News  Pedro Medrano on Facebook
VP - Regulatory Affairs
Gretchen Richards
  Gretchen Richards LinkedIn Profile  Gretchen Richards Twitter Account  Gretchen Richards News  Gretchen Richards on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/26/2017: VenatoRx Pharmaceuticals venture capital transaction
Next: 7/26/2017: Milestone Pharmaceuticals venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to record every notable VC transaction. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary